Immunosuppressive Agents: all 5,940 studies that test it

Page 8 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.

• Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient SettingCompletedNCT05108805Phase 4Results posted
• COVID Protection After Transplant-Immunosuppression ReductionCompletedNCT05077254Phase 2Results posted
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisCompletedNCT05071664Phase 2Results posted
• COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell LymphomaActive, not recruitingNCT04980222Phase 2Results posted
• Novel Use of Cyclosporine Ophthalmic Emulsion 0.05% in a PROSE DeviceCompletedNCT04918823Phase 1/2Results posted
• A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to MethotrexateActive, not recruitingNCT04909801Phase 3Results posted
• Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)CompletedNCT04908865Phase 4Results posted
• Belantamab Mafodotin, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple MyelomaTerminatedNCT04896658Phase 1/2Results posted
• A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune EncephalitisTerminatedNCT04875975Phase 2Results posted
• Uproleselan, Cladribine, and Low Dose Cytarabine for the Treatment of Patients With Treated Secondary Acute Myeloid LeukemiaCompletedNCT04848974Phase 1/2Results posted
• ALPN-101 (Acazicolcept) in Systemic Lupus ErythematosusCompletedNCT04835441Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rozanolixizumab Administered Subcutaneously Via Manual Push Versus Syringe Driver to Healthy ParticipantsCompletedNCT04828343Phase 1Results posted
• Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy SubjectsCompletedNCT04788641Phase 1Results posted
• Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only ImmunosuppressionCompletedNCT04786067Phase 4Results posted
• Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)CompletedNCT04783935Phase 4Results posted
• Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)CompletedNCT04776213Phase 4Results posted
• Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase MonotherapyCompletedNCT04772313Phase 4Results posted
• Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple SclerosisTerminatedNCT04767698Phase 2Results posted
• A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)CompletedNCT04762498Phase 4Results posted
• A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid ArthritisCompletedNCT04740814Phase 1Results posted
• Bioequivalence Study of Tacrolimus in Healthy VolunteersCompletedNCT04725682Phase 1Results posted
• Using Triamcinolone Acetonide to Reduce Pain After Scleral Buckle SurgeryCompletedNCT04701593Phase 4Results posted
• Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) PatientsCompletedNCT04667949Phase 4Results posted
• A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia GravisCompletedNCT04650854Phase 3Results posted
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04596995Phase 3Results posted
• Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC InfantsCompletedNCT04595513Phase 1/2Results posted
• CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19CompletedNCT04575038Phase 2Results posted
• Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent MalignancyCompletedNCT04532372Phase 1/2Results posted
• Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young AdultsTerminatedNCT04530487Phase 2Results posted
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving MethotrexateCompletedNCT04511702Phase 4Results posted
• Cyclosporine For The Treatment Of COVID-19(+)CompletedNCT04492891Phase 2Results posted
• Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory CompromiseTerminatedNCT04472494Phase 2Results posted
• Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative DisordersCompletedNCT04463615Phase 2Results posted
• Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19CompletedNCT04425252Phase 1/2Results posted
• Envarsus XR in Lung TransplantCompletedNCT04420195Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After ImmunotherapyTerminatedNCT04393454Phase 2Results posted
• Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung CancerTerminatedNCT04348292Phase 1Results posted
• Sirolimus Treatment in Hospitalized Patients With COVID-19 PneumoniaCompletedNCT04341675Phase 2Results posted
• Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell TransplantationCompletedNCT04339101Phase 2Results posted
• Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal InjuryTerminatedNCT04331002Phase 2Results posted
• Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic AnemiaCompletedNCT04328727Phase 2Results posted
• STOP-T1D Low-Dose (ATG)TerminatedNCT04291703Phase 2Results posted
• Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney FunctionTerminatedNCT04258423Phase 3Results posted
• A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04224688Phase 3Results posted
• Glenohumeral Cortisone InjectionCompletedNCT04216017Phase 2Results posted
• Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple MyelomaTerminatedNCT04205240Phase 2Results posted
• Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor PathwayCompletedNCT04200911Early Phase 1Results posted
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)TerminatedNCT04200456Phase 3Results posted
• CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit PatientsCompletedNCT04195945Phase 2Results posted
• Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisCompletedNCT04186871Phase 2Results posted
• Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric BursitisCompletedNCT04182672Phase 2Results posted
• Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT04179032Phase 2Results posted
• Immune Monitoring to Facilitate Belatacept MonotherapyCompletedNCT04177095Phase 4Results posted
• Enhancing Self Regulation Among SmokersCompletedNCT04161144Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive CapsulitisTerminatedNCT04160091Phase 2Results posted
• The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative VitreoretinopathyCompletedNCT04136366Phase 3Results posted
• A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia GravisCompletedNCT04124965Phase 3Results posted
• Nivolumab, Ixazomib, Cyclophosphamide, and Dexamethasone in Relapsed/Refractory MyelomaTerminatedNCT04119336Phase 2Results posted
• GOLimumab and Methotrexate Versus Methotrexate in Very Early PsACompletedNCT04108468Phase 3Results posted
• A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)TerminatedNCT04107675Phase 2Results posted
• Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver TransplantCompletedNCT04104438Phase 4Results posted
• Fingolimod as a Treatment of Cerebral Edema After Intracerebral HemorrhageCompletedNCT04088630Early Phase 1Results posted
• Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerCompletedNCT04081389Phase 1Results posted
• Treg Modulation With CD28 and IL-6 Receptor AntagonistsCompletedNCT04066114Phase 1/2Results posted
• Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the HipCompletedNCT04065074Phase 2Results posted
• Everolimus Monotherapy as Immunosuppression After Liver TransplantTerminatedNCT04063865Phase 3Results posted
• A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT04051944Phase 2Results posted
• RAPA-Keloid Study of Keloid RegressionCompletedNCT04049552Early Phase 1Results posted
• Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant PatientsCompletedNCT04041219Phase 4Results posted
• Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLLCompletedNCT04030195Phase 1/2Results posted
• Symptom Clusters in Children With Exacerbation-prone AsthmaCompletedNCT04002362Phase 2Results posted
• Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AMLTerminatedNCT04002115Phase 2Results posted
• Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor TenosynovitisTerminatedNCT04002037Phase 4Results posted
• Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled GoutCompletedNCT03994731Phase 4Results posted
• Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail PsoriasisCompletedNCT03991936Phase 4Results posted
• Envarsus XR Compared to Immediate Release TacrolimusCompletedNCT03979365Phase 4Results posted
• A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia GravisCompletedNCT03971422Phase 3Results posted
• Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple SclerosisCompletedNCT03963375Phase 4Results posted
• TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)CompletedNCT03959241Phase 3Results posted
• High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT03945591Phase 2Results posted
• Split-Dose R-CHOP for Older Adults With DLBCLActive, not recruitingNCT03943901Phase 2Results posted
• Sirolimus in Previously Treated Idiopathic Multicentric Castleman DiseaseActive, not recruitingNCT03933904Phase 2Results posted
• Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)CompletedNCT03930264Phase 1Results posted
• IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction CancerCompletedNCT03918499Phase 1/2Results posted
• The Effect of Intra-articular Bilateral Knee Injections of Zilretta on Performance Measures in Adults With Knee OACompletedNCT03895840Phase 4Results posted
• A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid ArthritisCompletedNCT03882008Phase 4Results posted
• PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT03873805Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric ParticipantsTerminatedNCT03870763Phase 3Results posted
• Envarsus in Delayed Graft Function (E-DGF)CompletedNCT03864926Phase 4Results posted
• A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyCompletedNCT03861481Phase 2Results posted
• Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)CompletedNCT03841357Phase 3Results posted
• A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for ResectionCompletedNCT03834740Early Phase 1Results posted
• Dose-Ranging Efficacy and Safety Study of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis ComplexCompletedNCT03826628Phase 2/3Results posted
• Envarsus Neurotoxicity Burden in Liver Transplant PatientsCompletedNCT03823768Phase 4Results posted
• Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersActive, not recruitingNCT03816332Phase 1Results posted
• Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT03813147Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip OsteoarthritisTerminatedNCT03793010Phase 3Results posted
• A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)TerminatedNCT03783923Phase 3Results posted
• Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid ArthritisTerminatedNCT03781375Phase 3Results posted

← Immunosuppressive Agents overview